Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Matsuda-Nagasumi
K. Matsuda-Nagasumi
Takeda Pharmaceutical Company
Free fatty acid receptor 1
Insulin
Insulin resistance
Endocrinology
Internal medicine
2
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TAK‐875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β‐cell dysfunction in Zucker diabetic fatty rats
2013
British Journal of Pharmacology
Ryo Ito
Yoshiyuki Tsujihata
K. Matsuda-Nagasumi
I Mori
N Negoro
Koji Takeuchi
Show All
Source
Cite
Save
Citations (30)
Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition
2013
Diabetes, Obesity and Metabolism
K. Matsuda-Nagasumi
R. Takami-Esaki
Kimihiko Iwachidow
Yoshitaka Yasuhara
Hideyuki Tanaka
Kazuhiro Ogi
Mitsugu Nakata
Takashi Yano
Shuji Hinuma
Shigehisa Taketomi
Hiroyuki Odaka
Yoshihiko Kaisho
Show All
Source
Cite
Save
Citations (19)
1